BGM Group Ltd. Class A Ordinary Shares (BGM)

• Market cap: $231M
• 1 day: -1.51%
• 5 days: -16.76%
• 1 month: 14.42%
• 3 months: 32.24%
• 6 months: 123.42%
• Year to date: 164.49%
• 1 year: 246.53%
• 5 years: -83.02%
• 10 years: -83.02%

About: BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.

Employees: 298

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.01% more ownership

Funds ownership: 0% [Q2] → 0.01% (+0.01%) [Q3]

0% more funds holding

Funds holding: 2 [Q2] → 2 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

82% less capital invested

Capital invested by funds: $20.1K [Q2] → $3.59K (-$16.5K) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1